Details for New Drug Application (NDA): 208253
✉ Email this page to a colleague
NDA 208253 describes ACTICLATE CAP, which is a drug marketed by Chartwell Rx and is included in one NDA. It is available from one supplier. Additional details are available on the ACTICLATE CAP profile page.
The generic ingredient in ACTICLATE CAP is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
The generic ingredient in ACTICLATE CAP is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
Summary for 208253
| Tradename: | ACTICLATE CAP |
| Applicant: | Chartwell Rx |
| Ingredient: | doxycycline hyclate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 208253
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ACTICLATE CAP | doxycycline hyclate | CAPSULE;ORAL | 208253 | NDA | Aqua Pharmaceuticals | 16110-601 | 16110-601-01 | 60 CAPSULE in 1 BOTTLE (16110-601-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Apr 26, 2016 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
